PHESGO
Google image searchProduct monograph
Active ingredients
trastuzumab, 60 MG/ML
pertuzumab, 60 MG/ML
DIN: 02512920
Dosage form(s): SOLUTION
Route(s) of administration: SUBCUTANEOUS
Description: SINGLE USE VIAL
Schedule: Prescription / Schedule D
Company: HOFFMANN-LA ROCHE LIMITED
Date: 09-APR-2021
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01F — MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES (ATC, ATC/DDD)
- L01FY — Combinations of monoclonal antibodies and antibody drug conjugates (ATC, ATC/DDD)
- L01FY01 — PERTUZUMAB AND TRASTUZUMAB (ATC/DDD)
External Links for Phesgo
Search on Google
- Phesgo side effects
- Phesgo dosage
- trastuzumab side effects
- trastuzumab dosage
- pertuzumab side effects
- pertuzumab dosage
Hoffmann-La Roche Limited
Go to Hoffmann-La Roche website to see drug product details. Sometimes you can find phesgo photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.